BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011

May 24, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-05-20

Reporting Person: Cooper Jeffrey H (SVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-05-20	Common Stock	M	2000	—	Acquired	37876	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-05-20	Restricted Stock Units	$0	M	2000	Disposed		Common Stock (2000)	Direct

Footnotes

F1: Represents restricted stock units which automatically converted to common stock upon the vesting of such units on a one-to-one basis, pursuant to restricted stock units granted May 22, 2008.

F2: Original grant of restricted stock units vests 1/4th each on June 22, 2009, May 22, 2010, May 22, 2011, and May 22, 2012.